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The small RNA-directed viral immunity pathway in
plants and invertebrates begins with the production
by Dicer nuclease of virus-derived siRNAs (viRNAs),
which guide specific antiviral silencing by Argonaute
protein in an RNA-induced silencing complex (RISC).
Molecular identity of the viral RNA precursor of
viRNAs remains a matter of debate. Using Flock
house virus (FHV) infection of Drosophila as a model,
we show that replication of FHV positive-strand RNA
genome produces an 400 bp dsRNA from its 50 ter-
minus that serves as the major Dicer-2 substrate.
ViRNAs thus generated are loaded in Argonaute-2
and methylated at their 30 ends. Notably, FHV-en-
coded RNAi suppressor B2 protein interacts with
both viral dsRNA and RNA replicase and inhibits pro-
duction of the 50-terminal viRNAs.Our findings, there-
fore, provide a model in which small RNA-directed
viral immunity is induced during the initiation of viral
progeny (+)RNA synthesis and suppressed by B2
inside the viral RNA replication complex.
INTRODUCTION
Small RNAs that are 21–24 nt long mediate viral immune re-
sponses in many eukaryotic hosts (Baulcombe, 2004; Ding and
Voinnet, 2007; Waterhouse et al., 2001). The viral immunity path-
way in plants and invertebrates overlaps the RNA silencing/RNA
interference (RNAi) pathway and begins with production of virus-
derived siRNAs (viRNAs) by Dicer nuclease, which then guide
specific antiviral silencing by Argonaute protein in an RNA-in-
duced silencing complex (RISC). In mammals, silencing of viral
mRNAs by viral and cellular miRNAs also plays a key role in path-
ogenesis and immunity (Gottwein and Cullen, 2008; Lecellier
et al., 2005; Otsuka et al., 2007; Pfeffer et al., 2004; Sullivan
et al., 2005; Umbach et al., 2008).Cell HosiRNAs are processed by Dicer from perfect dsRNA, whereas
production of miRNAs involves recognition of structured stem-
loop regions in a single-stranded (ss) RNA precursor (Hannon,
2002; Hammond, 2005). However, in organisms such as plants
and C. elegans that encode RNA-directed RNA polymerase
(RDR) genes, a target ssRNA may be converted first to dsRNA
before being diced into siRNAs. Recent genetic studies have
shown that the siRNA-producing Dicers—Dicer-2 (DCR2) of
Drosophila melanogaster and Dicer-like 2 (DCL2), DCL3, and
DCL4 of Arabidopsis thaliana—are required for the biogenesis
of viRNAs from several distinct positive-strand (+) RNA viruses
(Bouche et al., 2006; Deleris et al., 2006; Diaz-Pendon et al.,
2007; Fusaro et al., 2006; Galiana-Arnoux et al., 2006; Wang
et al., 2006). A genetic requirement in viral immunity has also
been established for several additional genes from the canoni-
cal dsRNA-siRNA RNAi pathway that are dispensable for the
function of miRNAs in A. thaliana, D. melanogaster, and Caeno-
rhabditis elegans (Ding and Voinnet, 2007). A key role for the
dsRNA-siRNA pathway in the RNAi-mediated viral immunity
implicates viral dsRNA as the trigger of the immunity, which is
supported by the cloning and sequencing of approximately
equal ratios of positive- and negative-strand () viRNAs from
two plant (+)RNA viruses and a fungal (+)RNA virus (Ho et al.,
2007; Yoo et al., 2004; Zhang et al., 2008) since (+)RNA viruses
accumulate 60- to 100-fold higher viral (+)RNAs than ()RNAs in
the infected cells. However, the viral RNA synthesis machinery
is associated with intracellular membrane structures, and it is
unclear when and where antiviral Dicer(s) may gain access to
the transient dsRNA region of the viral replicative intermediates
(vRI-dsRNA) embedded in these membrane structures. Indeed,
the molecular nature of the viral RNA precursor of viRNAs is still
under debate because viRNAs accumulated in plants infected
with four distinct plant (+)RNA viruses, as well as two subviral
pathogenic ssRNAs, correspond predominantly to the polarity
of the genomic RNA (Du et al., 2007; Ho et al., 2007; Itaya
et al., 2007; Molnar et al., 2005). In addition, host genes impli-
cated in antiviral silencing include cellular RDR genes that con-
trol dsRNA synthesis from ssRNA targets and others that have
dual function in both miRNA and siRNA pathways (Ding and
Voinnet, 2007).st & Microbe 4, 387–397, October 16, 2008 ª2008 Elsevier Inc. 387
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tion when the genome of pathogenic viruses encodes a protein
capable of suppressing RNAi, designated viral suppressor of
RNAi (VSR). Diverse plant and animal viruses, including those
with a genome of (+)RNA, ()RNA, dsRNA, ssDNA or dsDNA,
have been shown to encode VSRs (Li and Ding, 2006). Use of
well-defined transgene silencing models in plants together with
studies in vitro has identified many distinct mechanisms of
VSRs. These include inhibition of dicing and siRNA assembly
into RISC by sequestering dsRNA and siRNA, respectively,
direct targeting of Argonaute protein (AGO) by protein-protein
interaction, and suppression of RNA silencing spread (Ding
and Voinnet, 2007; Mlotshwa et al., 2008). Less is known about
how VSRs suppress antiviral silencing induced by their cognate
viruses during the course of infection. Most of the plant VSRs
were known to enhance virus accumulation in the inoculated
single cells (protoplasts), promote cell-to-cell virus movement
in the inoculated leaves, or facilitate the phloem-dependent
long-distance virus spread prior to their identification as VSRs
(Diaz-Pendon and Ding, 2008). Recent studies using VSR-defi-
cient viral mutants and A. thaliana mutants defective in specific
RNA silencing pathway components began to address how
various VSR activities might account for their known roles in
the distinct steps during host infection (Deleris et al., 2006;
Diaz-Pendon et al., 2007).
Flock house virus (FHV) and Nodamura virus (NoV), both nat-
ural pathogens of insects, are members of the Nodaviridae, con-
tain a 4.5 kb bipartite (+)RNA genome and have been used as
a model to study RNA replication (Venter and Schneemann,
2008). RNA2 encodes CP precursor, and RNA1 encodes B2
and the viral RNA-dependent RNA polymerase (RdRP) protein
A, the only viral protein needed for RNA replication. Thus,
RNA1 replicates in absence of RNA2, whereas RNA2 replication
is RNA1 dependent. Unlike protein A and CP that use the geno-
mic RNAs as mRNA, B2 is translated from RNA3, which is a sub-
genomic RNA templated by RNA1. FHV infection of Drosophila
cells induces the formation of membranous vesicles called
‘‘spherules’’ on the outer mitochondrial membrane in which pro-
tein A is localized and RNA replication occurs (Kopek et al., 2007;
Miller et al., 2001; Venter and Schneemann, 2008). Infection of
Drosophila with FHV induces the RNAi immunity in the DCR2/
AGO2 canonical RNAi pathway and requires expression of the
VSR B2 (Galiana-Arnoux et al., 2006; Li et al., 2002, 2004; Lu
et al., 2005; van Rij et al., 2006; Wang et al., 2006). Studies
in vitro indicate a dual function for B2, which forms an all a-helix
homodimer that binds to both long dsRNA and siRNA to inhibit
siRNA production and siRNA assembly into RISC, respectively
(Chao et al., 2005; Lingel et al., 2005; Lu et al., 2005; Sullivan
and Ganem, 2005).
Here, we describe a strongly biased production of an approx-
imately equal ratio of (+) and () viRNAs targeting the 50-terminal
region of the genomic RNA inDrosophila cells abortively infected
with a B2-deficient mutant of FHV, indicating that initiation of the
progeny (+)RNA synthesis triggers processing of the 50-terminal
nascent vRI-dsRNA into viRNAs. In cells successfully infected
with FHV, B2 acts as a structural component of the viral RNA rep-
lication complex to inhibit production of viRNAs, including the 50-
terminal viRNAs, even though B2 is dispensable for RNA replica-
tion. Our findings, thus, establish a model on the induction and388 Cell Host & Microbe 4, 387–397, October 16, 2008 ª2008 Elsevisuppression of the small RNA-directed viral immunity in Dro-
sophila during the course of infection.
RESULTS
B2 Inhibits DCR2-Dependent Production of Viral siRNAs
We have previously developed a protocol for examining the self-
replication of FHV RNA1 in Drosophila embryos by microinjec-
tion of full-length FHV RNA1 (FR1) synthesized in vitro (Wang
et al., 2006). We scaled up embryo microinjection in this study
to analyze the biogenesis of viRNAs, which was not investigated
in previous studies.
Abundant accumulation of viRNAs was detected in ago-2414
embryos injected with FR1DB2, but viRNAs were not detectable
in dcr-2L811fsX embryos injected with FR1DB2, although replica-
tion of FR1DB2 was as robust in dcr-2L811fsX embryos as in
ago-2414 embryos (Figure 1A, lanes 6 and 9). viRNAs were also
detected in FR1DB2-injected wild-type (WT) embryos
(Figure 1A, lane 3), albeit at a markedly reduced level compared
to that in ago-2414 embryos, despite the fact that FR1DB2 repli-
cated to extremely low levels in WT embryos and detection of
FR1DB2 replication required overexposure as compared to
that in either ago-2414 or dcr-2L811fsX embryos (Figure 1A).
Thus, these data indicate an essential role of DCR2 in the bio-
genesis of viRNAs. In contrast, neither AGO2 nor DCR1 may
contribute significantly to viRNA biogenesis since viRNAs were
undetectable in dcr-2L811fsX embryos in which DCR1-dependent
production of miRNAs is not affected (Lee et al., 2004) and abun-
dant viRNAs were detected in ago-2414 embryos.
We found that, despite the robust viral RNA replication in
embryos of all three of the genotypes following FR1 injection,
viRNAs were below the level of detection not only in
dcr-2L811fsX embryos but also in both WT and ago-2414 embryos
(Figure 1A, lanes 2, 5, and 8). Thus, expression of B2 during viral
RNA replication strongly inhibited the DCR2-dependent produc-
tion of viRNAs in Drosophila embryos.
We next examined the production of FHV siRNAs in cultured
Drosophila cells (Li et al., 2002). FR1DB2 replicates to detectable
levels in S2 cells (Figure 1B, lane 3) only when RNAi is sup-
pressed by AGO2 depletion or expression of B2 (Figure 1B, lanes
4 and 5). Production of viRNAs from FR1DB2 was detected in
cells after RNAi suppression by AGO2 depletion (dsAgo2)
(Figure 1B, lane 5), but not by expression of NoV B2 (NB2)
(Figure 1B, lane 4). In addition, viRNAs were also undetectable
following replication of FHV RNA1 that expresses B2
(Figure 1B, lane 2). Thus, as found in embryos, expression of
B2 during viral RNA replication in S2 cells also markedly reduced
the production of viRNAs. Without interference of B2 in viRNA
production, the expected correlation between viral RNA replica-
tion and viRNA production was observed: higher levels of
FR1DB2 replication in ago-2414 embryos and AGO2-depleted
S2 cells resulted in higher levels of viRNA accumulation as com-
pared to those in WT embryos and S2 cells (Figure 1).
We further examined the production of FHV siRNAs in
Drosophila S2 cells infected directly with virions of either the
cloned isolate of FHV or its B2-deficinet mutant, FHVDB2. As
expected, FHVDB2 replicated to extremely low levels in the
infected cells in the absence of viral suppression of the RNAi
immunity, as compared to those in cells infected with mucher Inc.
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Accumulation of viral RNAs 1 and 3 (upper panel) and viRNAs (lower panel) 2 days after microinjection into embryos (A) or transcriptional induction in S2 cells (B) of
FHV RNA1 (FR1), FR1DB2, or FR1fs, the last of which contains a frameshift mutation in the viral RdRP gene. Top left of (A) shows an overexposure of lanes 1–3.
viRNAs were detected by 11 oligos hybridizing to the complementary strand of ORF B2 in (B) or by oligo probes targeting the positive and negative strands of
the 50-terminal region of RNA1 in (C), which were extracted from S2 cells 72 hr after inoculation with virions of FHVDB2 or FHV in a series of 10-fold dilutions
(lanes 4–11). Equal loading was monitored by probing for RP49 or U6.diluted wild-type FHV inoculum (Figure 1C). However, extremely
abundant accumulation of viRNAs was detected in FHVDB2-
infected cells, whereas little viRNAs were produced during the
high-level viral RNA replication in the presence of B2 (Figure 1C).
The ratio of viRNAs to the genomic RNAs was at least 100-fold
higher in FHVDB2-infected cells than in FHV-infected cells, indi-
cating that aborted infection of FHVDB2 was associated with
highly abundant production of viRNAs. Thus, B2 also inhibited
viRNA production in FHV-infected Drosophila cells, consistent
with the results obtained from self-replication of FHV RNA1 in
absence of RNA2.
B2 expression markedly reduced, but did not eliminate, the
production of viRNAs in S2 cells because viRNAs were detected
in S2 cells infected with WT FHV (Figure 1C, lower panels, lanes 4
and 5) and inoculation with a higher multiplication of infection
yielded more abundant accumulation of viRNAs (e.g.,
Figure 1A in Li et al., 2002). However, viRNAs became inactive
in antiviral silencing and unable to inhibit the robust replication
of FHV (Figure 1C, lane 4), which directed expression of B2
that binds to viral siRNAs (Figure S3B available online), in con-
trast to potent antiviral silencing directed by low levels of viRNAs
when B2 was not expressed (Figure 1A, lane 3). This indicates
that B2 suppresses the antiviral activity of viRNAs in addition
to inhibiting siRNA production, as suggested by previous
in vitro studies using synthetic dsRNA and siRNAs (Chao et al.,
2005; Lu et al., 2005; Sullivan and Ganem, 2005).Cell HosviRNAs Are Loaded in AGO2 and Methylated
at Their 30 Ends
We noted that FR1DB2 replicated to high levels in both ago-2414
embryos and AGO2-depleted S2 cells in spite of the abundant
accumulation of viRNAs, but a much lower level of viRNAs was
sufficient to direct viral clearance in either WT embryos or S2
cells where AGO2 was active (Figure 1). Thus, AGO2 is required
for the antiviral activity of viRNAs, whereas AGO1 does not
appear to play a role in the viral immunity in the absence of
AGO2. In support of this view, we found that viRNAs of both
polarities were coimmunoprecipitated from FHVDB2-infected
S2 cells by a monoclonal AGO2 antibody (Figure 2A, lane 3),
but not by a monoclonal AGO1 antibody (Figure 2A, lane 2). As
expected from previous studies (Kawamura et al., 2008; Siomi
et al., 2008), our control experiments showed that immunopre-
cipitated AGO1, but not AGO2, was associated with miRNA-
bantam (miR-ban) (Figure 2A, lanes 2 and 3); similarly, immuno-
precipitated AGO2, but not AGO1, was associated with the
endogenous (endo) siRNA esiRNA-sl-1 (Figure 2, lanes 2 and 3).
Drosophila miRNAs loaded in AGO1 show sensitivity to peri-
date oxidation and beta elimination treatments. In contrast,
PIW-interacting RNAs (piRNAs) and endo-siRNAs are resistant
to these treatments because these small RNAs loaded in PIWI
and AGO2 proteins, respectively, are methylated at their 30
ends by the Drosophila ortholog of the A. thaliana HEN1
(Siomi et al., 2008; Yu et al., 2005). We found that viRNAst & Microbe 4, 387–397, October 16, 2008 ª2008 Elsevier Inc. 389
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oxidation and beta elimination treatments, as was esiRNA-sl-1,
whereas viRNAs in the input prior to coimmunoprecipitation
were partially sensitive to the treatments (Figure 2B, compare
lanes 2 and 4). As expected, miR-ban coimmunoprecipitated
with AGO1 was sensitive to peridate oxidation and beta elimina-
tion treatments (data not shown). These findings indicate that
viRNAs loaded in AGO2 are methylated at their 30 ends, whereas
a portion of viRNAs in the input are unmethylated at the 30 ends.
Thus, it is likely that the unmethylated viRNAs are free-floating
since no viRNA was coimmunoprecipitated with AGO1.
Profiling viRNAs Produced during Infection
To profile viRNAs produced in infected cells without the interfer-
ence of B2, we next sequenced the small RNAs from Drosophila
cells infected with FHVDB2. The small RNA library made from S2
cells 4 days after infection with FHVDB2 virions was deposited
into one of the four regions of a Pico Titer Plate for pyrosequenc-
ing. In total, 4371 small RNAs of 18–28 nucleotides in length were
obtained. These include 106 known Drosophila miRNAs (2.4%)
and 1177 FHV-specific small RNAs (27%) if one nucleotide mis-
match was allowed (Table S1). We considered only the 834 small
RNAs that are 100% identical or complementary to the bipartite
RNA genome of FHV, representing20% of the total small RNAs
sequenced (Figures 3A and 3B), as FHVDB2 virions used were
derived from the cloned FHV isolate (Li et al., 2002). Many FHV
small RNAs were sequenced two to four times (Figure 3C), and
most (89%) were 20 to 22 nucleotides in length with a major
peak at 21 nucleotides (60.3%) (Figure S1A). The length distribu-
tion of the sequenced FHV small RNAs was similar to that of the
cloned siRNAs processed in vitro from synthetic dsRNA by
Drosophila embryo Dicer extracts and the recently sequenced
Drosophila endogenous siRNAs (Elbashir et al., 2001; Siomi
et al., 2008). Thus, we conclude that the sequenced FHV small
Figure 2. Characterization of viRNAs in the Infected Cells
(A) viRNAs are associated with AGO2, but not AGO1, in infected Drosophila
cells. AGO1 and AGO2 were immunoprecipitated, respectively, by specific an-
tibodies 4 days after inoculation with FHVDB2 virions, and bound small RNAs
were analyzed by northern blot hybridizations using probes specific to (+) and
() viRNAs, miR-ban and esiRNA-sl-1.
(B) viRNAs loaded in AGO2 were resistant to peridate oxidation and beta elim-
ination treatments (b), whereas viRNAs in the input before immunoprecipitation
were partially sensitive. The samples used were identical to lanes 1 and 3 of (A).390 Cell Host & Microbe 4, 387–397, October 16, 2008 ª2008 ElsevRNAs corresponded to the viRNAs detected by northern hybrid-
izations.
The sequenced viRNAs from FHVDB2-infected Drosophila
cells exhibited three notable features. First, 479 and 356 viRNAs
were mapped to the 3.1 kb long RNA1 and the 1.4 kb long RNA2,
respectively. Thus, the density of viRNAs is higher for RNA2 (254
viRNAs/kb) than RNA1 (154 viRNAs/kb). It is possible that this
Figure 3. Examining the Population of viRNAs Produced inDrosoph-
ila Cells
(A and B) Profiles of viRNAs cloned by the 50-ligation-independent method
from S2 cells abortively infected with FHVDB2 virions. Reads of viRNA were
plotted to the positive (top) and negative (bottom) strands of RNA1 (A) and
RNA2 (B) with 5 nt windows.
(C) A close-up view of the distribution and abundance of (+) and () viRNAs in
the 50-terminal 400 nt region of RNA1. 264 reads were from this region, includ-
ing 153 (+)viRNAs (58%, top) and 111 ()viRNAs (42%, bottom). Counts of
distinct viRNAs are shown by color-coded bars.
(D) Relative abundance of viRNAs targeting the seven evenly divided regions of
RNA1 (shown on top of each lane and of the graph in [A]) in S2 cells 4 days after
inoculation with virions of FHV (bottom) or FHVDB2 (top). Equal loading was
shown by staining with ethidium bromide.ier Inc.
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strands of RNA2 than RNA1 in the FHV-infected cells (Kopek
et al., 2007).
Second, 57% and 43% of the sequenced viRNAs were map-
ped to the positive and negative strands of either RNA1 or
RNA2, respectively (Figure 3A). Since the genomic RNAs of
FHV accumulate to 100-fold higher in the infected cells than
the antigenomic RNAs (Kopek et al., 2007), presence of an
approximately equal ratio of (+) and () viRNAs in the small RNA
library indicates that vRI-dsRNA, rather than structured regions
of viral (+) and () ssRNAs, serves as the substrate of DCR2.
Third, we observed an incomplete bias in the positions of
viRNAs mapped on the viral genomic and antigenomic RNAs.
Strikingly, more than 60% of the sequenced RNA1-specific
viRNAs were clustered in the 50-terminal region of about 400
nucleotides long (Figures 3A and S1C). 58% and 42% of these
50-terminal viRNAs corresponded to the genomic and antige-
nomic RNA1, respectively (Figure 3C), similar to the ratio found
for the total viRNAs sequenced. The (+)viRNAs targeting the 50-
terminal 200 nt region of RNA2 were also very abundant; in con-
trast to RNA1, however, the ()viRNAs were distributed more
uniformly along the entire genomic RNA2 (Figure 3B and S1C).
We next focused on the RNA1-specific viRNAs because RNA1
self-replicates unlike RNA2, which depends on RNA1 for replica-
tion in an undefined manner. We examined the distribution pat-
tern of RNA1-specific viRNAs in Drosophila cells infected by
FHVDB2 by blot hybridizations using an established protocol
(Szittya et al., 2002). Briefly, DNA fragments representing the
seven evenly divided regions of RNA1 (445 nt except the 30-ter-
minal fragment, which is 8 nt shorter; Figures 3A and 3D) were
synthesized by PCR, and equal amounts of each DNA fragment
were probed with the 32P-labeled 20–24 nt small RNAs isolated
from Drosophila cells abortively infected with FHVDB2 virions.
The results showed first an extremely low density of viRNAs tar-
geting the middle region of RNA1, which was supported by the
pyrosequencing results (Figures 3A and 3D, fragment 4). Sec-
ond, the 50-terminal fragment (fragment one) produced by far
the strongest signal among the seven fragments of RNA1
(Figure 3D, upper panel with the number above each lane corre-
sponding to one of the seven regions of RNA1 indicated at the
top of Figure 3A). This indicates that a large proportion of viRNAs
produced in FHVDB2-infected cells corresponded to the 50-ter-
minal region of RNA1, which is, thus, in agreement with the
results from pyrosequencing (Figure 3A). Like all of the (+)RNA
viruses, FHV accumulates 100-fold higher viral (+)RNAs than
()RNAs in the infected cells by multiple initiation of the progeny
(+)RNA synthesis on the 30 terminus of the antigenomic RNA
template (Kopek et al., 2007). Thus, the strong biased production
of an approximately equal ratio of (+) and () viRNAs targeting
the 50-terminal 400 nt region of RNA1 further identifies the dsRNA
region of the viral replicative intermediates (vRI-dsRNA) between
the nascent, 50-terminal region of the progeny (+)RNA1 and the
30-terminal region of the ()RNA1 template formed during initia-
tion of the progeny (+)RNA synthesis as the predominant source
of viRNAs.
Probing the same panel of RNA1-specific DNA fragments with
small RNAs isolated from FHV-infected cells (Figure 3D, lower
panel) revealed two major differences between viRNA produc-
tion and that observed in FHVDB2-infected cells. First, viRNAsCell Hocorresponding to the 50-terminal fragment of RNA1 were not
more abundant than viRNAs corresponding to fragments 2, 3,
6, and 7 of RNA1 (Figure 3D, lower panel), in contrast to the
strong bias for the 50-terminal viRNAs in FHVDB2-infected cells.
This indicates that the massive production of viRNAs targeting
the nascent vRI-dsRNA during initiation of the progeny (+)RNA
synthesis was inhibited by B2 in FHV-infected cells. Second,
we reproducibly observed a modestly increased production of
viRNAs corresponding to the 30-terminal fragment of RNA1 as
compared to the other fragments of RNA1 in FHV-infected cells
(Figure 3D, lower panel). By contrast, the 30-terminal viRNAs
were of a similar abundance to viRNAs corresponding to frag-
ments 2, 3, and 6 of RNA1 in FHVDB2-infected cells (Figure 3D,
upper panel). As the 437 nt fragment 7 includes the 30-terminal
region of 387 nucleotides identical in sequence to RNA3, the
30-terminal viRNAs could be triggered by the synthesis of either
RNA3 templated by ()RNA1 or ()RNA1 from the incoming
(+)RNA1, which was not effectively blocked by B2.
B2 Interacts with Viral Duplex RNAs in Infected
Drosophila Cells
One interpretation for the observed suppression of 50-terminal
viRNA production by B2 is that B2 is located in close proximity
to the nascent vRI-dsRNA during RNA replication. Both FHV
and NoV B2 proteins (FB2 and NB2) bind long dsRNA and siRNA
in vitro and inhibit both in vitro processing of long dsRNA into
siRNAs and RNAi induced by siRNA (Chao et al., 2005; Lu
et al., 2005; Sullivan and Ganem, 2005). FB2 and NB2 mutants
containing Gln substitution at the conserved Arg (R/Q;
Figure S2) were defective in RNA binding and in the suppression
of both dicing in vitro and antiviral RNAi in the infected S2 cells
(Lu et al., 2005; Figure S2), indicating that nodoviral B2 acts by
sequestering dsRNA. By comparing these in vitro and in vivo
activities, we found that the single R/Q substitution was
more effective in eliminating the VSR activity of NB2 than that
of FB2 (Lu et al., 2005; Figure S2).
We next performed a GST pull-down assay to investigate
whether B2 interacts with vRI-dsRNA and viRNAs during viral
RNA replication. In this assay, GST-tagged WT and mutant B2
proteins were expressed during replication of FR1DB2 in S2 cells
treated with AGO2 dsRNA. Depletion of AGO2 ensured similarly
robust replication of the VSR-deficient FR1DB2 (Figure 4A, lanes
5–8 of left panel), as only two of the four fusion proteins examined
(GST-FB2 and GST-NB2) were active VSRs even through west-
ern blot analysis revealed similar expression levels for all fusion
proteins (Figure S3A). Lysates obtained 2 days after initiation
of viral RNA replication were incubated with glutathione beads,
and RNAs bound to the beads were fractionated in polyacryl-
amide and agarose gels for northern blot detection of small
and large RNAs, respectively. Both negative- and positive-
strand viRNAs of 21 nt, but not host miRNAs, were pulled
down and markedly enriched by GST-NB2, but not by GST-
mNB2 (Figure S3B). This indicates that B2 complexes with
viRNAs produced during viral replication in Drosophila cells.
Northern blot hybridizations also detected large FHV-specific
RNA molecules pulled down by both GST-NB2 and GST-FB2
(Figure 4A, lanes 2 and 4 of right panel). The two major RNA spe-
cies in complex with B2 migrated approximately at the positions
of FHV RNA 1 and RNA3, respectively. Two lines of evidencest & Microbe 4, 387–397, October 16, 2008 ª2008 Elsevier Inc. 391
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Infected S2 Cells
(A) Northern blot analysis of viral RNAs in S2 cells before
(lanes 4–8 of left panel) and after (right panel) GST pull-
down. S2 cells were cotransfected with pFR1DB2 and
dsRNA of AGO2 plus a plasmid expressing GST alone
(lane 1 of left panel and lanes 1, 6, and 11 of right panel),
GST-tagged WT (lanes 5 and 7 of left panel and lanes 2,
4, 7, 9, 12, and 14 of right panel) or (R/Q) mutant B2
(lanes 6 and 8 of left panel and lanes 3, 5, 8, 10, 13, and
15 of right panel) of FHV and NoV. 5% of total RNA before
GST pull-down was analyzed in the left panel. Right panel
shows the RNA pulled down by GST with treatment of
RNase I (lanes 6–10), RNase III (lanes 11–15), or without
RNase treatment (lanes 1–5).
(B) Northern blot analysis of viral RNAs in mock-infected
S2 cells and S2 cells infected with virions of FHV or
FHVDB2 before (input) and after coimmunoprecipitation
(IP) with the antibody to B2 of FHV. S2 cells were pre-
treated with dsRNA of AGO2 before inoculation with
FHVDB2 virions, which is essential to ensure successful
infection. The strand-specific probes recognized positive
and negative strands of FHV RNA1 and RNA3, respec-
tively; each contained 11 50-labeled, 40 nt single-strand
DNA oligos hybridizing to the positive and negative
strands of the ORF B2 coding region. The RNA species
that migrated at the positions of FHV RNA1 and RNA3
were marked. Asterisk (*) indicates an RNA species that
may correspond to the homodimer of RNA1 implicated
in FHV replication. Methylene blue staining of the filter
was shown at the bottom.indicate that these viral RNA species pulled down by B2 were
double stranded. First, the B2-bound RNA species were com-
pletely degraded by treatment with the dsRNA-specific RNase
III (Figure 4A, lanes 11–15 of right panel), but not by treatment
with RNase I (Figure 4A, lanes 7–10 of right panel), which de-
grades ssRNA only. Second, much fewer viral RNAs were pulled
down with either GST-mFB2 or GST-mNB2 (Figure 4A, lanes 3
and 5 of right panel), both of which were defective in dsRNA
binding in vitro. In particular, the RNA species bound by NB2
were RNase I resistant, but RNase I treatment completely de-
graded the residual RNA species bound by mNB2 (Figure 4A,
compare lanes 1 and 8 of right panel), which was defective in
binding to dsRNA in vitro (Figure S2C, lanes 3, 4, 7, and 8).
We next performed coimmunoprecipitation experiments with
polyclonal antibody raised against GST-FB2 with lysates pre-
pared from S2 cells 12 hr postinfection with virions of either
FHV or FHVDB2. Total RNA extracted both from the lysates be-
fore coimmunoprecipitation (input) and from the coimmunopre-
cipitated complex (IP) was fractionated in two identical agarose
gels, which were blotted and probed for positive and negative
strands of FHV RNAs, respectively (Figure 4B). The two major
RNA species that migrated approximately at the positions of
FHV RNAs 1 and 3 were detected in the complex coimmunopre-
cipitated by the B2 antibody from the lysates of FHV-infected
cells, but not from the lysates of FHVDB2-infected cells
(Figure 4B, compare lanes 4 and 9 with lanes 5 and 10). FHV rep-392 Cell Host & Microbe 4, 387–397, October 16, 2008 ª2008 Elsevilication produces 100-fold more positive-strand RNAs than
negative-strand RNAs (Kopek et al., 2007). However, in contrast
to the positive-strand viral RNAs, the negative-strand viral RNAs
were selectively enriched in the coimmunoprecipitated complex
as compared to the extremely low level of the negative-strand
viral RNAs present in the input (Figure 4B, lanes 1 and 2). These
results indicate that, in the infected cell, B2 associates with viral
dsRNA rather than viral (+) and () ssRNAs that were annealed
subsequently into dsRNA during RNA extraction.
B2 Interacts with the Viral Replicase In Vivo
Our observation that B2 complexes with the extremely low-
abundant viral RNA replication intermediates in infected cells
suggests that B2 might interact directly with protein A, the FHV-
encoded RdRP. To test this idea, complexes were coimmuno-
precipitated from the lysates of S2 cells 12 hr postinfection
with FHV virion by the antibody to either B2 or protein A before
western blotting analysis. Both B2 and protein A were detected
in the complexes precipitated by either the B2 antibody
(Figure 5A, lane 1) or the protein A antibody (Figure 5A, lane 2).
However, neither protein A nor B2 was detectable in the complex
precipitated from the FHV-infected cells by the preimmune anti-
body (Figure 5A, lane 3) or in the complex precipitated from the
mock-infected cells by the B2 antibody (Figure 5A, lane 4). These
data suggest that at least a fraction of B2 is in a specific complex
with the viral replicase. To investigate whether B2 binds toer Inc.
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complex precipitated by the B2 antibody was subjected to treat-
ments of RNase A in low and high salt concentrations before
fractionation by denaturing polyacrylamide gel electrophoresis
Figure 5. Specific Interaction of B2 and Viral RdRP In Vivo
(A and B) Coimmunoprecipitation of B2 and protein A of FHV in FHV-infected
cells. Total crude protein extracts (Input) prepared 12 hr after mock inoculation
or inoculation with FHV virions were immunoprecipitated (IP) with polyclonal
antibody to B2 or protein A. A preimmune antibody was used as a negative
control. Western blots were analyzed with the same antibodies to detect coim-
munoprecipitated proteins. The proteins coimmunoprecipitated by the B2 an-
tibody were treated with RNase A under high (H) or low (L) salt concentrations
before fractionation and western blot analysis (lanes 1 and 2 of [B]).
(C) Interaction of B2 and protein A in S2 cells in which RNA1 self-replicates in
absence of RNA2. Total crude protein extracts (Input) prepared in S2 cells
48 hr after induction of viral RNA replication were immunoprecipitated (IP)
with either polyclonal antibody to B2 (lanes 1 and 2) or the preimmune antibody
(lane 3). Mock-transfected S2 cells were used as a negative control (lane 4). As
described for Figure 1B, AGO2 was depleted by dsRNA in S2 cells transfected
with pFR1DB2 to ensure robust replication of FR1DB2 (lane 2).Cell Ho(Figure 5B). RNase A degrades both dsRNA and ssRNA in low
salt concentration but digests ssRNA specifically in high salt
concentration (Tacken et al., 2002). We found that RNase A treat-
ment at either salt condition did not obviously disrupt the protein
A-B2 complex (Figure 5A, compare lane 3 with lanes 1 and 2),
indicating a direct binding of protein A by B2.
We next investigated whether B2 interacted with protein A dur-
ing RNA1 self-replication in absence of RNA2 and the capsid
protein encoded by RNA2. Lysates of S2 cells 48 hr after replica-
tion of FR1 or FR1DB2 were immunoprecipitated by the B2 anti-
body. Protein A was detected in cells transfected with either
pFR1 or pFR1DB2, whereas B2 was detected only in cells trans-
fected with pFR1, but not with pFR1DB2 (Figure 5C, lanes 6 and
7). Also, as expected, no viral proteins were detected in the com-
plex precipitated by the preimmune antibody from pFR1-trans-
fected cells (Figure 5C, lane 3). However, western blot analysis
revealed the presence of both protein A and B2 in the complex
precipitated by the B2 antibody from pFR1-transfected cells,
but not from pFR1DB2-transfected cells (Figure 5C, lanes 1
and 2), indicating a specific in vivo interaction between B2 and
protein A in the absence of viral coat protein.
DISCUSSION
Mechanism of Induction of the Small
RNA-Directed Viral Immunity
How the RNAi-mediated viral immunity is induced during the
course of infection is poorly understood in both plants and inver-
tebrate animals. This is at least in part because of the frequent
use of WT viruses for infection that express VSRs to interfere
with the production and/or antiviral activity of viRNAs. Use of
a B2-deficient FHV mutant in this study demonstrates that
viRNAs are produced by DCR2, but DCR1 plays an undetectable
role. We found that viRNAs are loaded in AGO2, but not in AGO1.
Loaded viRNAs are methylated at their 30 ends, but there are
unmethylated viRNAs in the infected cells, unlike Drosophila
endo-siRNAs (Siomi et al., 2008). Since Drosophila HEN1 does
not methylate duplex small RNAs (Siomi et al., 2008), unmethy-
lated viRNAs presented in the infected cells may be double
stranded possibly due to saturation of viRNA loading into
AGO2. Similarly, the abundant viRNAs detected in ago-2414 em-
bryos may be double stranded and methylated. Pyrosequencing
of viRNAs in Drosophila cells infected with FHVDB2 further re-
vealed an approximately equal ratio of (+) and () viRNAs target-
ing both RNA1 and RNA2. This finding identified the vRI-dsRNA
as the viral precursor of viRNAs because (+) and () viral RNAs
accumulate asymmetrically in the infected cells. Thus, the small
RNA-directed viral immunity in Drosophila is mediated by
a viRNA pathway that overlaps both the canonical dsRNA-siRNA
pathway and the recently identified endo-siRNA pathway, but
neither DCR1 nor AGO1 from the miRNA pathway may be di-
rectly involved (Hammond, 2005; Siomi et al., 2008). This conclu-
sion is consistent with previous genetic studies that implicate the
canonical RNAi pathway in antiviral silencing in several inverte-
brate animal species, including D. melanogaster (Galiana-
Arnoux et al., 2006; Keene et al., 2004; Li et al., 2002, 2004;
van Rij et al., 2006; Wang et al., 2006).
In addition to triggering antiviral RNAi in plants and inverte-
brates, vRI-dsRNA has been proposed as a pathogen-associatedst & Microbe 4, 387–397, October 16, 2008 ª2008 Elsevier Inc. 393
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MDA5 helicases in mammals (Ishii et al., 2008). As predicted
from the replication cycle of a ssRNA genome, dsRNA of at least
40 bp long in the infected cells has been detected for a number of
plant and animal (+)RNA viruses (Ahlquist, 2006 ; Weber et al.,
2006). However, (+)RNA viruses may produce vRI-dsRNA during
the synthesis of either the ()RNA template from the incoming
(+)RNA genome or the viral progeny (+)RNA from the ()RNA tem-
plate, as well as during transcription of subgenomic RNAs from
the ()RNA template of some (+)RNA viruses. It is unknown
whether vRI-dsRNA synthesized from a particular step of viral
RNA replication is detected by any of these dsRNA-specific
host immune receptors. Examination of the viRNA population
by pyrosequencing and gel blot hybridizations revealed that initi-
ation of the FHV progeny (+)RNA1 synthesis on the 30-terminal re-
gion of the ()RNA template produces vRI-dsRNA molecules of
about 400 bp that are accessible to DCR2 for dicing into viRNAs.
Our findings support a model for FHV and perhaps other (+)RNA
viruses (Figure 6A) in which the RNAi-mediated viral immunity is
triggered during the initiation of the progeny (+)RNA synthesis,
which is necessary to yield the 100-fold higher viral progeny
(+)RNA than ()RNA template. We propose that dicing of the
initiating vRI-dsRNA during the progeny (+)RNA synthesis is in-
hibitory to viral replication and that this first wave of 50-terminal
viRNAs may play a more important role in the abortive infection
of Drosophila cells by FHVDB2 than the low-abundant viRNAs
targeting the remaining region of RNA1.
Current models envision that, prior to RNA replication, protein
A recruits RNA1 to the outer mitochondrial membranes, where
FHV RNA replication complexes form inside spherules by self-
interaction and membrane targeting of protein A (Kopek et al.,
2007; Venter and Schneemann, 2008). Our observation that the
initiating vRI-dsRNA during the synthesis of progeny (+)RNA1
is diced into viRNAs suggests that DCR2 is in a close proximity
to the site of viral RNA replication. We did not observe any obvi-
ous phasing in the production of viRNAs, including the 50-termi-
nal viRNAs. Thus, DCR2 may initiate siRNA processing from mul-
tiple positions of the initiating vRI-dsRNA, unlike the phased
production of siRNAs from a defined end of dsRNA precursors
(Chapman and Carrington, 2007). At present, it is unknown
why there is an abrupt drop in viRNA abundance beyond the
50-terminal 400 nucleotides of RNA1 and why the density of
viRNAs targeting the rest of RNA1, the middle region in particu-
lar, is very low. We propose that there might be polarity in FHV
RNA1 synthesis in the viral replication complex so that vRI-
dsRNA formed during the initiation of RNA synthesis is much
more readily accessible to DCR2 for dicing than the internal
region. Dicing of the 50-terminal initiating vRI-dsRNA by DCR2
would also inhibit the elongation of nascent vRI-dsRNA toward
the 30 end of RNA1, further reducing the abundance of viRNAs
beyond the 50-terminal 400 nucleotides of RNA1. Consistent
with this hypothesis, increased production of the 30-terminal
viRNAs of RNA1 was detected in FHV-infected cells in which
dicing of the 50-terminal initiating vRI-dsRNA was suppressed
by B2. Compared to RNA1, RNA2 has a higher density of viRNAs
than RNA1, and the accumulation of the 50-terminal (+) and ()
viRNAs of RNA2 is asymmetrical. It is unknown whether either re-
flects a difference in the biogenesis influenced by the mode of
RNA2 replication, which is RNA1 dependent and exhibits com-394 Cell Host & Microbe 4, 387–397, October 16, 2008 ª2008 Elsevplex regulatory features distinct to RNA1 (Venter and Schnee-
mann, 2008).
Mechanism of Viral Suppression of the
Small RNA-Directed Viral Immunity
Little is known about the cell biology of viral suppression of the
small RNA-directed viral immunity during the course of infection
(Ding and Voinnet, 2007). Previous in vitro studies using syn-
thetic RNAs have indicated that B2 suppresses both dicing
and slicing by binding and sequestering long dsRNA and siRNA,
respectively (Chao et al., 2005; Lu et al., 2005; Sullivan and Ga-
nem, 2005). GST pull-down experiments showed that B2 binds
to viRNAs in the infected cells. Thus, viRNA sequestering by
B2, perhaps in a nonmembrane-bound cytoplasmic fraction,
may indeed play a role in the suppression of antiviral silencing
(Figure 6B), as suggested previously for B2 and demonstrated
for the tombusviral p19 (Vargason et al., 2003). Notably, results
of this study explain why B2 gains access to the low-abundant
vRI-dsRNA located inside the viral RNA replication complex.
Both GST pull-down experiments and coimmunoprecipitation
Figure 6. Model for the Induction and Suppression of theDrosophila
RNAi Immunity by FHV
Asymmetric RNA synthesis in the replication of (+)RNA viruses involves multi-
ple initiation of the progeny (+)RNA synthesis on the low-abundant ()RNA
template complexed with the viral RdRP and other host factors. The resulting
dsRNA of 400 nt in length formed between the 50-terminal nascent progeny
(+)RNA1 and the ()RNA1 template in FHV-infected cells, termed the initiating
vRI-dsRNA, serves as substrates of DCR2. This results in the predominant
production of 50-terminal viRNAs, thereby triggering the RNAi-mediated viral
immunity and abortive infection by FHVDB2 (A). In addition to binding to
viRNAs, B2 is part of the viral RNA replication complex by direct interactions
with viral RdRP (protein A) and vRI-dsRNA and inhibits DCR2-dependent pro-
duction of viRNAs, thus ensuring successful infection by FHV. We propose that
sequestering the initiating vRI-dsRNA and inhibiting their processing into the
50-terminal viRNAs by B2 plays a particularly important role in the suppression
of the viral immunity (B).ier Inc.
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vRI-dsRNA in Drosophila cells infected with FHV. B2 also inter-
acts with the viral protein A in a manner that depends on neither
binding to dsRNA nor the presence of capsid protein. We also
showed that B2 expressed from its cognate virus inhibits the pro-
duction of viRNAs in Drosophila cells following either RNA1 self-
replication or infection with FHV virions.
Based on these findings, we propose that, although non-
essential for RNA replication, B2 is a structural component of
the viral RNA replication complex via interactions with both vRI-
dsRNA and the viral RdRP, thereby inhibiting the dicing of the ini-
tiating vRI-dsRNA into viRNAs (Figure 6B). In this regard, the to-
bamoviral VSR p126 is similar to B2 since p126 is part of the viral
RNA replication complex, but unlike its readthrough product
p183, it is not essential for viral replication (Ding et al., 2004;
Kubota et al., 2003; Komoda et al., 2007; Lewandowski and
Dawson, 2000). Moreover, we found that expression of B2 in
FHV-infected cells inhibits the production of the abundant 50-ter-
minal viRNAs of RNA1, which is consistent with the model that
B2 suppresses production of viRNAs in close proximity to the
RNA replication complex. It is of interest to note that suppression
of the dicing of the 50-terminal initiating vRI-dsRNA of RNA1 by
B2 was accompanied with a modest increase in the production
of the 30-terminal viRNAs (Figure 3D), which could be processed
from vRI-dsRNA formed during the initiation of either ()RNA1
synthesis from (+)RNA or the synthesis of RNA3 templated by
RNA1. Thus, B2 does not appear to inhibit the production of
viRNAs targeting the 30-terminal region of RNA1, raising an in-
triguing possibility that B2 may be absent at the site where the
30-terminal viRNAs are produced (Figure 6B).
EXPERIMENTAL PROCEDURES
Cell Culture, Plasmids, and Antibodies
Culture, transfection, and FHV infection of S2 cells and microinjection of in vitro
FHV transcripts to Drosophila embryos were performed as described (Wang
et al., 2006). Rabbit polyclonal antisera against FHV protein A and monoclonal
anti-AGO1 and anti-AGO2 antibodies were generous gifts from Dr. Paul Ahl-
quist (Miller et al., 2001) and Mikiko C. Siomi (Miyoshi et al., 2005), respectively.
Polyclonal antisera against FHV B2 protein fused with GST was prepared by
Santa Cruz Biotechnology.
Plasmids pMT-FR1, pMT-FR1DB2, pMT-NR1, and pMT-NR1DB2 were as
described (Li et al., 2002, 2004). pMT-mFB2 and pMT-mNB2 were generated
by introducing a point mutation by PCR substituting Arg at position 54 (FB2) or
59 (NB2) to Glu. The mutant B2 coding sequences carrying the point mutation
(TCGA to TCAA for FHV and TCGG to TCAG for NoV with Arg encoded by the
underlined codon, whereas the first triplet encodes Ser of protein A) were used
to replace the corresponding regions in pMT-FR1and pMT-NR1 to yield
FR1mB2 and NR1mB2, respectively, without altering the sequence of protein
A in the 1 reading frame. GST-B2 fusion protein expression constructs
pMT-GST-FB2, pMT-GST-mFB2, pMT-GST-NB2, and pMT-GST-mNB2
were made by fusing the GST coding sequence to the 50 end of the coding se-
quences of WT and mutant B2 proteins. All plasmids were verified by sequenc-
ing in the core facility of the UCR Institute for Integrative Genome Biology.
Construction of Small RNA Library, 454 Sequencing,
and Sequence Analysis
Cloning of small RNAs was carried out essentially as described (Sunkar and
Zhu, 2004). Briefly, 1 mg of total RNA from S2 cells 4 days postinoculation
with FHVDB2 virions, which were amplified in S2 cells pretreated with dsRNA
of AGO2, was extracted, fractionated by polyacrylamide gel electrophoresis
(PAGE). The gel slice containing small RNAs of 18–28 nucleotides long was
excised, and the eluted small RNAs were dephosphorylated before ligationCell Hoto the 30 and 50 linkers and amplification by RT-PCR. DNA products of about
100 bp were diluted to 2 3 105 molecules/ml, and 2.5 ml sample was added
to an emulsion PCR reaction mix plus 450,000 capture breads. This ratio favors
getting a single copy of library per capture bead in the emulsified reaction. The
resulting products were recovered by breaking emulsions and then enriching
for beads containing amplified products. Approximately 40,000 enriched
beads were deposited into one region of a Pico Titer Plate and run on a Genome
Sequencer FLX (Roche, Basel, Switzerland).
The sequences of FHV RNAs 1 and 2 (GenBank Accession NC_004146 and
NC_004144) were downloaded from NCBI. The adaptor sequences were
masked with crossmatch, and only these reads that contain both the 50 and
30 adaptors were kept. The reads (18–28 nt in length) were mapped to FHV
RNAs with BLASTN, and only those 100% identical or complementary to
FHV were kept for further analyses. All other analyses were carried out with
in-house scripts.
RNA and DNA Hybridizations, GST Pull-Down Assay,
and Coimmunoprecipitation
Northern blot hybridization to detect high and low molecular weight RNAs was
done as described previously (Guo and Ding, 2002; Li et al., 2002). Two sets of
11 DNA oligos (40 nt) targeting the B2 region and two sets of 13 DNA oligos
targeting the 50-terminal 400 nt of RNA1 were used to detect positive-and neg-
ative-strand viRNAs. Based on the sequenced viRNAs, four DNA oligos com-
plementary to nucleotides 106–126, 327–347, 363–383, and 369–389 of FHV
RNA1 were used as probes for the detection of 50-terminal (+)viRNAs.
DNA fragments corresponding to seven evenly divided regions of RNA1 (445
nt except fragment 7 that was 437 nt) were amplified by PCR. 300 ng of each
fragment plus a LacZ fragment was fractionated in 1.2% agarose gel. DNA
blotting and hybridization with g-32P-ATP-labeled small RNAs of 20–24 nt
size range isolated from S2 cells 4 days postinoculation with FHV or FHVDB2
virions were as described (Szittya et al., 2002).
Coimmunoprecipitation with the monoclonal antibodies to AGO1 and AGO2
and peridate oxidation and beta elimination treatments of small RNAs were as
described (Miyoshi et al., 2005; Kawamura et al., 2008). GST pull-down assay
and coimmunoprecipitation to detect protein-protein and protein-RNA com-
plexes were described in the Supplemental Data.
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